Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Trial of Oral L-arginine and / or Vitamin D as Adjunctive Therapies in Pulmonary Tuberculosis in Papua Province, Indonesia.

NCT00677339 is registered in ClinicalTrials.gov with Menzies School of Health Research as lead sponsor.

NCT NCT00677339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00677339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Trial of Oral L-arginine and / or Vitamin D as Adjunctive Therapies in Pulmonary Tuberculosis in Papua Province, Indonesia.
Lead sponsor
Menzies School of Health Research
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2008
Completion date
May 31, 2010
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

smear positive pulmonary tuberculosis